Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0, signaling a minor page revision. This update appears to be a label-only change and does not modify the study content or results.
    Difference
    0.1%
    Check dated 2026-06-26T20:38:22.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page now indicates recruitment is closed for participants, and new help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), along with a formatting adjustment from 'Intervention / Treatment' to 'Intervention/Treatment' and a new revision version (v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-12T13:27:13.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.4 to v3.5.5, indicating a new internal revision was applied. This update does not modify visible study information.
    Difference
    0.1%
    Check dated 2026-06-05T10:37:54.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a new page revision label 'Revision: v3.5.4' and removed the previous 'Revision: v3.5.3'. This indicates a minor update to the page's versioning metadata without altering the study content or available information.
    Difference
    0.1%
    Check dated 2026-05-15T04:14:33.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.2 to v3.5.3, signaling a minor platform/software update to the study page rather than a change to study content or results. No study data, eligibility criteria, or outcomes are altered by this update.
    Difference
    0.1%
    Check dated 2026-04-30T17:50:06.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is displayed, replacing Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:43:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.